Alzheimer’s disease neuropathological change co-pathology. The level of ADNPC was measured in all groups (Montine et al., 2012). Intermediate and high levels of ADNPC were rare except in the PSP and nLBD group. Definite and possible PART was common across the majority of groups (Crary et al., 2014). AD = Alzheimer’s disease; MPG = minimal pathology group.